Genetics and Diagnostic Testing
At a Glance
HNF1B-related disease may be caused by a disease-causing change within the HNF1B gene or by a deletion of the 17q12 region. A complete evaluation may require gene sequencing and a separate test for missing gene sections; an affected parent has a 50% chance of passing the change to each child.
The human body is built according to a complex set of instructions found in our DNA. When you are diagnosed with HNF1B-related disease, it means there is a change involving a specific gene called HNF1B. To understand this diagnosis, it helps to look at how this gene works and how laboratories test for it.
The Master Controller: HNF1B
The HNF1B gene provides instructions for making a transcription factor—a type of protein that turns other genes on and off at exactly the right time during a baby’s development [1].
Because it is so active during development, HNF1B is essential for building several organs:
- Kidneys: It guides the branching of the tubes that filter blood and helps organize the cells into the correct structure [2][3].
- Pancreas: It helps maintain the early cells that will eventually become the parts of the pancreas that produce insulin and digestive enzymes [4].
- Liver and Reproductive Tract: It plays a role in forming the bile ducts in the liver and the structures that become the uterus or other reproductive organs [5][6].
When this gene is altered or missing, these organs may not develop their full size or internal organization, which is why this condition can affect so many different systems.
Mutations vs. Deletions: Why Testing Methods Matter
There are two main ways the HNF1B instructions can go wrong. Your genetic report will likely mention one of these:
- Intragenic Sequence Variant (Mutation): The chromosome is intact, but there is a specific change within the HNF1B gene itself. Note that a laboratory must classify a variant as “pathogenic” or “likely pathogenic” to confirm a diagnosis; a “variant of uncertain significance” (VUS) does not establish the diagnosis [7].
- 17q12 Deletion: The entire HNF1B gene is missing, along with neighboring genes [8][9].
Why this matters for testing: Detection depends entirely on the assay and the laboratory pipeline. Some standard genetic sequencing panels (like older Next-Generation Sequencing or Sanger sequencing) are designed to find sequence variants but may not detect missing sections (deletions) [10][11].
To find a deletion if a sequencing panel is negative, laboratories often use specialized copy-number tools:
- MLPA (Multiplex Ligation-dependent Probe Amplification): This test specifically checks for missing copies of the gene [12].
- Chromosomal Microarray (CMA): This looks across the chromosomes to see if a larger chunk, like the 17q12 region, is absent [13].
- CNV (Copy Number Variant) Calling: Some modern sequencing platforms include robust software to detect deletions [14].
Always ask your doctor or genetic counselor if deletion/duplication analysis was included in your test.
How It Is Inherited
About 50% of people diagnosed with an HNF1B change are the first person in their family to have it; this is called a de novo (new) finding [15][5]. In other cases, the change was passed down from a parent.
The inheritance pattern is autosomal dominant. This means:
- You only need one changed copy of the gene to have the condition.
- If a parent has the change, there is a 50% chance in each pregnancy that it will be passed to the child [16].
- The severity can vary wildly—a parent might have very mild symptoms, while their child has more significant kidney issues [17][18].
Planning for the Future
For families who know they carry a pathogenic HNF1B variant or a 17q12 deletion and are planning a pregnancy, there are reproductive options available.
One option is PGT-M (Preimplantation Genetic Testing for Monogenic disorders). This involves using In Vitro Fertilization (IVF) to test embryos for the familial genetic change [19]. Other families may choose prenatal testing during pregnancy, such as CVS (Chorionic Villus Sampling) or amniocentesis, to learn if the fetus has inherited the change [18]. These are optional, technically complex, and deeply values-sensitive procedures. They offer information and the option to select embryos, but they do not guarantee a healthy outcome, and PGT-M requires laboratory-specific validation. A genetic counselor can provide decision support based on your personal values.
Common questions in this guide
What can an HNF1B genetic test show?
Can routine HNF1B sequencing miss a 17q12 deletion?
How is HNF1B-related disease inherited?
Should my relatives be tested for an HNF1B change?
What reproductive testing options are available for HNF1B-related disease?
Get notified when new evidence is published on HNF1B-related autosomal dominant tubulointerstitial kidney disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
The Role of HNF1B in Tumorigenesis of Solid Tumours: a Review of Current Knowledge.
Bártů M, Dundr P, Němejcová K, et al.
Folia biologica 2018; (64(3)):71-83 doi:10.14712/fb2018064030071.
PMID: 30394265 - 2
HNF1B controls epithelial organization and cell polarity during ureteric bud branching and collecting duct morphogenesis.
Desgrange A, Heliot C, Skovorodkin I, et al.
Development (Cambridge, England) 2017; (144(24)):4704-4719 doi:10.1242/dev.154336.
PMID: 29158444 - 3
New insights into the role of HNF-1β in kidney (patho)physiology.
Ferrè S, Igarashi P
Pediatric nephrology (Berlin, Germany) 2019; (34(8)):1325-1335 doi:10.1007/s00467-018-3990-7.
PMID: 29961928 - 4
Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors.
De Vas MG, Kopp JL, Heliot C, et al.
Development (Cambridge, England) 2015; (142(5)):871-82 doi:10.1242/dev.110759.
PMID: 25715395 - 5
The role of hepatocyte nuclear factor 1β in disease and development.
El-Khairi R, Vallier L
Diabetes, obesity & metabolism 2016; (18 Suppl 1()):23-32 doi:10.1111/dom.12715.
PMID: 27615128 - 6
A novel mutation of the HNF1B gene associated with hypoplastic glomerulocystic kidney disease and neonatal renal failure: a case report and mutation update.
Alvelos MI, Rodrigues M, Lobo L, et al.
Medicine 2015; (94(7)):e469 doi:10.1097/MD.0000000000000469.
PMID: 25700310 - 7
Molecular impact of a novel HNF1B missense variant in childhood-onset MODY5: a case report and functional study.
Umeda C, Imagawa E, Hokazono S, et al.
Frontiers in endocrinology 2026; (17()):1814139 doi:10.3389/fendo.2026.1814139.
PMID: 42158912 - 8
MODY5 and 17q12 Microdeletion Syndrome: Phenotype Variability, Prenatal and Postnatal Counseling.
Fontana P, Costabile C, Falco M, et al.
Genes 2025; (16(9)) doi:10.3390/genes16091002.
PMID: 41009948 - 9
17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5.
Roehlen N, Hilger H, Stock F, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(10)):3601-3610 doi:10.1210/jc.2018-00955.
PMID: 30032214 - 10
Hypertriglyceridemia as a main feature associated with 17q12 deletion syndrome-related hepatocyte nuclear factor 1β-maturity-onset diabetes of the young.
Thewjitcharoen Y, Nakasatien S, Tsoi TF, et al.
Endocrinology, diabetes & metabolism case reports 2022; (2022()).
PMID: 36106561 - 11
A Case of Diabetes Mellitus Type MODY5 as a Feature of 17q12 Deletion Syndrome
Yaşar Köstek H, Özgüç Çömlek F, Gürkan H, et al.
Journal of clinical research in pediatric endocrinology 2024; (16(2)):205-210 doi:10.4274/jcrpe.galenos.2022.2022-3-2.
PMID: 36511482 - 12
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia.
Wang Y, Xiao X, Lin Q, et al.
Journal of diabetes investigation 2024; (15(1)):121-130 doi:10.1111/jdi.14084.
PMID: 37737534 - 13
17q12 deletion and duplication syndrome in Denmark-A clinical cohort of 38 patients and review of the literature.
Rasmussen M, Vestergaard EM, Graakjaer J, et al.
American journal of medical genetics. Part A 2016; (170(11)):2934-2942 doi:10.1002/ajmg.a.37848.
PMID: 27409573 - 14
Simplifying Detection of Copy-Number Variations in Maturity-Onset Diabetes of the Young.
Berberich AJ, Wang J, Cao H, et al.
Canadian journal of diabetes 2021; (45(1)):71-77 doi:10.1016/j.jcjd.2020.06.001.
PMID: 33011132 - 15
De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemia.
Stiles CE, Thuraisingham R, Bockenhauer D, et al.
Endocrinology, diabetes & metabolism case reports 2018; (2018()).
PMID: 29576871 - 16
Pediatric patient with maturity-onset diabetes of the young type 5 and 17q12 deletion syndrome: A case report.
Rico-Rodríguez M, Fuentes-Cantero S, García-Rivera MC, Varo-Sánchez GM
Medicine international 2025; (5(5)):61 doi:10.3892/mi.2025.260.
PMID: 40901483 - 17
17q12 Recurrent Deletion Syndrome in Childhood.
Ceravolo G, Mollica S, Cavallaro M, et al.
Genes 2025; (16(12)) doi:10.3390/genes16121499.
PMID: 41465172 - 18
Prenatal diagnosis and family analysis of 17q12 microdeletion syndrome with fetal renal abnormalities.
Zhang F, Gu Q, Song J, et al.
Frontiers in genetics 2024; (15()):1401315 doi:10.3389/fgene.2024.1401315.
PMID: 38957807 - 19
A Diagnosis of Maturity-onset Diabetes of the Young Type 5 Provides Clarity and Broadens Reproductive Options.
Conn JJ, Walsh M, Kane SC, et al.
JCEM case reports 2025; (3(9)):luaf165 doi:10.1210/jcemcr/luaf165.
PMID: 40741598
This page explains HNF1B genetic testing and inheritance for educational purposes and does not replace medical advice. Discuss your results, family testing, and reproductive options with a qualified clinician or genetic counselor.